-
Ancient Greek theatre revives legendary Callas opera Medea
-
Indian guru urges broader view of yoga
-
Portugal's unofficial exorcism fever worries Church
-
Paraguay's Almiron sent off under new FIFA 'mouth-covering' rule
-
Ancelotti hails 'complete game' as Brazil sink Haiti at World Cup
-
Tunisia ask how Sweden World Cup star Ayari slipped its net
-
Scotland remain bullish despite Morocco World Cup setback
-
USA down Australia to reach World Cup knockout rounds, Brazil swat Haiti
-
Brazil cruise past Haiti to re-ignite World Cup campaign
-
Australia detects first case of contagious H5 bird flu
-
Scheffler career Slam chances blowing in Shinnecock winds
-
Iran's treatment at World Cup 'a dark point' for football: official
-
McIlroy seven back but likes his chances at US Open
-
Nagelsmann eyes same German lineup against I. Coast after Curacao trouncing
-
Clark leads US Open by four with major champs in the hunt
-
Saibari early strike gives Morocco World Cup win over Scotland
-
Archaeologists discover 'never before seen' pre-Hispanic ruins in Mexico
-
Pochettino backs 'high IQ' players to block out World Cup hype
-
James Burrows, prolific innovator in US TV comedies, dead at 85
-
Douglass breaks 50m free world record at Indy Pro Swim
-
World Cup warning with Sweden star Isak 'getting stronger and stronger'
-
'Like China': Cubans welcome reforms but exiles remain skeptical
-
Tunisia coach says 'I am no wizard' after World Cup SOS call
-
USA down Australia to reach World Cup knockout rounds
-
USA beat Australia 2-0 to reach World Cup knockouts
-
Imperious Dupont guides record-breaking Toulouse to Top 14 final
-
Qatar-gifted Air Force One replacement unveiled
-
Venezuelan opposition figure heads to US after transition talks
-
Niemann fires 65 at US Open after upsetting two-shot penalty
-
Canada star Kone to miss rest of World Cup after surgery: team
-
Spain's Yamal says 'too soon' to play full match at World Cup
-
Confident Fitzpatrick makes a run at another US Open title
-
Neymar? He is working remotely at the World Cup, jokes Lula
-
England captain Stokes strikes for Durham as Test recall looms
-
Three-time Stanley Cup champion Toews retires
-
Clark wants to win back fans as well as US Open title
-
Japan wary of fired up and wounded Tunisia for World Cup landmark game
-
Clark leads as fellow major winners charge at US Open
-
'Like a fridge': France cave homes offer lucky few respite from heat
-
Ton-up Nicholls turns the screw for New Zealand against England
-
Hormuz ship traffic climbs after war deal: trackers
-
Sun shines on jockey Lee at Royal Ascot
-
Kane hails World Cup 'Wonderwall' singalong as England highlight
-
Sabalenka roars back to make Berlin WTA semis
-
Europe swelters as more heat records set to tumble
-
Narvaez takes Swiss Tour third stage after 100km breakaway
-
'There's no soul': Tony Leung weighs in on AI in filmmaking
-
Europe swelters as temperature records tumble
-
From Versailles to a Swiss mountain: a week of dizzying Iran diplomacy
-
French mountain lodges worry over strained water supply
RFK Jr panel votes against ingredient targeted by anti-vaxxers
A newly appointed US medical panel voted Thursday to oppose the use of a vaccine ingredient long targeted by Health Secretary Robert F. Kennedy Jr. over debunked claims it causes autism.
Thimerosal, a preservative that prevents bacterial and fungal contamination in multidose vials, has been extensively studied, with authorities including the World Health Organization finding no evidence of harm beyond minor injection-site reactions.
Though thimerosal is now rarely used in US vaccines, its inclusion on the Advisory Committee on Immunization Practices' agenda alarmed experts, who say the move has effectively embedded anti-vaccine talking points into national policy.
Kennedy -- who spent decades spreading vaccine misinformation before becoming President Donald Trump's top health official -- abruptly fired all 17 ACIP members earlier this month, accusing them of conflicts of interest.
Across three votes, his new handpicked panelists recommended that thimerosal be removed from influenza vaccines for children, pregnant women and finally all adults.
Cody Meissner, a professor of pediatrics at Dartmouth University and the lone voice of dissent, said: "The risk from influenza is so much greater than the nonexistent risk as far as we know from thimerosal," adding that he was worried about the decision's global impact.
Although 96 percent of US flu vaccines in the 2024-2025 season did not contain thimerosal, the preservative remains important globally, particularly in multidose vials that must be punctured repeatedly, raising the risk of contamination.
Thimerosal contains an artificial form of mercury called ethylmercury that is cleared from the body far more quickly than the form of the substance found in nature.
US manufacturers voluntarily removed it from most pediatric vaccines in 2001.
- 'Platform for anti-vaccine talking points' -
"The fact that it's being brought up again -- something that's already been adjudicated -- shows how the ACIP is becoming a platform for anti-vaccine talking points to come back to life long after most of us thought they'd been put to rest," Amesh Adalja, an infectious disease specialist at Johns Hopkins University, told AFP.
Ahead of the vote, Lyn Redwood, a nurse and former leader of the anti-vaccine group Children's Health Defense, which Kennedy once chaired, was invited to present arguments against thimerosal.
A previous version of her slideshow, which was posted online before the meeting, was removed without explanation after it was found to contain a fabricated citation, likely the result of an AI hallucination.
The Centers for Disease Control and Prevention had prepared a rebuttal to Redwood's presentation, but it was mysteriously removed from the meeting website.
Robert Malone, a new panel member known for spreading misinformation during the Covid-19 pandemic, including promoting the antiparastic drug ivermectin to treat the virus, later said the CDC document had not been approved by the Office of the Secretary.
Earlier in the meeting, the same panel voted to recommend a new antibody treatment against RSV, a common respiratory illness and the leading cause of infant hospitalization in the United States.
Clesrovimab, recently approved by the Food and Drug Administration, is administered as a single shot to newborns and young babies entering their first respiratory syncytial virus season.
Marketed as Enflonsia by Merck, it was shown in clinical trials to significantly reduce RSV infections and hospitalizations among infants.
X.M.Francisco--PC